Dermal Fibroblast CCN1 Expression in Mice Recapitulates Human Skin Dermal Aging

Abstract The aging process deleteriously alters the structure and function of dermal collagen. These alterations result in thinning, fragility, wrinkles, laxity, impaired wound healing, and a microenvironment conducive to cancer. However, the key factors responsible for these changes have not been fully elucidated and relevant models for the study of skin aging progression are lacking. CCN1, a secreted extracellular matrix (ECM) associated matricellular protein, is elevated in dermal fibroblasts in aged human skin. Towards constructing a mouse model to study key factors involved in skin aging progression, we demonstrate that transgenic mice, with selective expression of CCN1 in dermal fibroblasts (COL1A2-CCN1), display accelerated skin dermal aging. The aged phenotype in COL1A2-CCN1 mice resembles aged human dermis: the skin is wrinkled, and the dermis is thin and composed of loose, disorganized, and fragmented collagen fibrils. These dermal alterations reflect reduced production of collagen due to impaired TGF-β signaling and increased expression of matrix metalloproteinases, driven up induction of c-Jun/AP-1. Importantly, similar mechanisms drive human dermal aging. Taken together, the data demonstrate that elevated expression of CCN1 by dermal fibroblasts functions as a key mediator of dermal aging. The COL1A2-CCN1 mouse model provides a novel tool for understanding and studying mechanisms of skin aging and age-related skin disorders.